<?xml version="1.0" encoding="UTF-8"?>
<?xml-stylesheet type="text/xsl" href="https://www.peertechzpublications.org/assets/xsl/oaitohtml.xsl"?>
<OAI-PMH xmlns="http://www.openarchives.org/OAI/2.0/" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:mml="http://www.w3.org/1998/Math/MathML" xsi:schemaLocation="http://www.openarchives.org/OAI/2.0/ http://www.openarchives.org/OAI/2.0/OAI-PMH.xsd">
										<responseDate>2026-05-25T00:34:43Z</responseDate>
										<request verb="GetRecord" metadataPrefix="oai_dc" identifier="oai:www.peertechzpublications.org:10.17352/2455-8605.000032">https://www.peertechzpublications.org/oai-pmh</request><GetRecord><record>
								<header>
									<identifier>oai:www.peertechzpublications.org:10.17352/2455-8605.000032</identifier>
									<datestamp>2019-07-20</datestamp>
									<setSpec>PTZ.IJDCR:VOL5</setSpec>
								</header>
								<metadata>
									<oai_dc:dc xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:oai_dc="http://www.openarchives.org/OAI/2.0/oai_dc/" xmlns:dc="http://purl.org/dc/elements/1.1/" xmlns:mml="http://www.w3.org/1998/Math/MathML" xsi:schemaLocation="http://www.openarchives.org/OAI/2.0/oai_dc/ http://www.openarchives.org/OAI/2.0/oai_dc.xsd">
										<dc:title>
										Low PD-1 expression and no prognostic impact in early-stage Mycosis Fungoides: 61 patients retrospective cohort analysis
										</dc:title><dc:creator>Gustavo Moreira Amorim1</dc:creator><dc:creator>2</dc:creator><dc:creator>3</dc:creator><dc:creator> Danielle Carvalho Quintella1</dc:creator><dc:creator> João Paulo Niemeyer Corbellini1</dc:creator><dc:creator> Luiz Claudio Ferreira4</dc:creator><dc:creator> Marcia Ramos-e-Silva1</dc:creator><dc:creator>2</dc:creator><dc:creator>Tullia Cuzzi1</dc:creator><dc:creator>2</dc:creator><dc:creator>4</dc:creator><dc:description>&lt;p&gt;&lt;strong&gt;Background&lt;/strong&gt;: Mycosis fungoides (MF) is an indolent behavior cutaneous T-cell lymphoma. Most patients present a slowly progressive course, over many years. However, some patients evolve early towards advanced stages of the disease, despite adequate treatment, having therefore, a worse prognosis. Increasing knowledge of risk factors that contribute to a better prognostic evaluation is considered of interest.&lt;/p&gt;&lt;p&gt;&lt;strong&gt;Aims&lt;/strong&gt;: Evaluate positivity and prognostic importance of PD-1 marker in early-stage MF. &lt;strong&gt;&lt;br&gt;&lt;/strong&gt;&lt;/p&gt;&lt;p&gt;&lt;strong&gt;Methods&lt;/strong&gt;: Retrospective cohort study with early-stage MF patients. Cases were defi ned by Pimpinelli criteria. PD-1 positivity was tested in complementary immunohistochemistry over the fi rst skin biopsies done in our hospital. Disease progression, death and MF-related death was investigated 5 years after the date of the diagnostic defi nition according to the proposed criteria. The hazard ratio was calculated as association measurement. Adopted signifi cance criterion was 5%.&lt;/p&gt;</dc:description>
										<dc:publisher>International Journal of Dermatology and Clinical Research - Peertechz Publications</dc:publisher>
										<dc:date>2019-07-20</dc:date>
										<dc:type>Research Article</dc:type>
										<dc:identifier>https://doi.org/10.17352/2455-8605.000032</dc:identifier>
										<dc:language>en</dc:language>
										<dc:rights>Copyright © Gustavo Moreira Amorim1 et al.</dc:rights>
									</oai_dc:dc>
								</metadata>
							</record></GetRecord>
						</OAI-PMH>
